The Analysis Study of Prevalence of Chronic Kidney Disease in Patients with Chronic Obstructive Pulmonary Disease : A Comprehensive Systematic Review
Keywords:
CKD, COPD, impact, prevalence, relationshipAbstract
Background: The relationship between COPD and chronic kidney disease (CKD) is complex, with CKD often overlooked in older populations. The study aims to investigate the prevalence, risk factors, and impact of CKD on mortality and renal failure, highlighting the need for comprehensive health care. Methods: Following PRISMA 2020 guidelines, this systematic review focused exclusively on full-text articles published in English between 2011 and 2024. Result: The study conducted a comprehensive review of over 8,000 publications sourced from reputable databases, including ScienceDirect, SagePub, and PubMed. Following an initial screening, eight publications were identified as warranting more in-depth analysis. Consequently, a thorough review of these selected studies was performed to ensure a detailed and rigorous evaluation. Conclusion: CKD is a significant risk factor for COPD patients, with 15.6% diagnosed aged 40 and older. Common risk factors include advancing age, diabetes, hypertension, elevated BMI, and cigarette smoking. COPD is associated with systemic inflammation, contributing to conditions like diabetes, muscle wasting, and kidney disease. Proactive management approaches are needed to address renal implications.
References
GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16. Erratum in: Lancet Respir Med. 2017 Oct;5(10):e30. doi: 10.1016/S2213-2600(17)30336-3. PMID: 28822787; PMCID: PMC5573769.
Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004 Jun;23(6):932-46. doi: 10.1183/09031936.04.00014304. Erratum in: Eur Respir J. 2006 Jan;27(1):242. PMID: 15219010.
Madouros N, Jarvis S, Saleem A, Koumadoraki E, Sharif S, Khan S. Is There an Association Between Chronic Obstructive Pulmonary Disease and Chronic Renal Failure? Cureus. 2022 Jun 21;14(6):e26149. doi: 10.7759/cureus.26149. PMID: 35891809; PMCID: PMC9302210.
Cavaillès A, Brinchault-Rabin G, Dixmier A, et al.: Comorbidities of COPD. Eur Respir Rev. 2013, 22:454-75. 10.1183/09059180.00008612
Chen W, FitzGerald JM, Sin DD, Sadatsafavi M; Canadian Respiratory Research Network. Excess economic burden of comorbidities in COPD: a 15-year population-based study. Eur Respir J. 2017 Jul 27;50(1):1700393. doi: 10.1183/13993003.00393-2017. PMID: 28751416.
Lisspers K, Larsson K, Johansson G, Janson C, Costa-Scharplatz M, Gruenberger JB, Uhde M, Jorgensen L, Gutzwiller FS, Ställberg B. Economic burden of COPD in a Swedish cohort: the ARCTIC study. Int J Chron Obstruct Pulmon Dis. 2018 Jan 11;13:275-285. doi: 10.2147/COPD.S149633. PMID: 29391785; PMCID: PMC5769573.
Corsonello A, Aucella F, Pedone C, Antonelli-Incalzi R. Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int. 2017 Nov;17(11):1770-1788. doi: 10.1111/ggi.13054. Epub 2017 May 16. PMID: 28509429.
Vaidya SR, Aeddula NR. Chronic Kidney Disease. [Updated 2024 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535404/#
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun;67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x. PMID: 15882252.
Sorino C, Scichilone N, Pedone C, Negri S, Visca D, Spanevello A. When kidneys and lungs suffer together. J Nephrol. 2019 Oct;32(5):699-707. doi: 10.1007/s40620-018-00563-1. Epub 2018 Dec 6. Erratum in: J Nephrol. 2020 Feb;33(1):187. doi: 10.1007/s40620-019-00643-w. PMID: 30523563.
Domenech P, Perez T, Saldarini A, Uad P, Musso CG. Kidney-lung pathophysiological crosstalk: its characteristics and importance. Int Urol Nephrol. 2017 Jul;49(7):1211-1215. doi: 10.1007/s11255-017-1585-z. Epub 2017 Apr 11. PMID: 28401379.
Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. PMID: 27383068; PMCID: PMC4934905.
Yoshizawa T, Okada K, Furuichi S, Ishiguro T, Yoshizawa A, Akahoshi T, Gon Y, Akashiba T, Hosokawa Y, Hashimoto S. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Int J Chron Obstruct Pulmon Dis. 2015 Jul 6;10:1283-9. doi: 10.2147/COPD.S80673. PMID: 26185434; PMCID: PMC4500615.
AbdelHalim HA, AboElNaga HH. Is Renal Impairment an Anticipated COPD Comorbidity? Respir Care. 2016 Sep;61(9):1201-6. doi: 10.4187/respcare.04516. Epub 2016 Apr 26. PMID: 27118874.
Chen CY, Liao KM. Chronic Obstructive Pulmonary Disease is associated with risk of Chronic Kidney Disease: A Nationwide Case-Cohort Study. Sci Rep. 2016 May 11;6:25855. doi: 10.1038/srep25855. PMID: 27166152; PMCID: PMC4863146.
Gaddam S, Gunukula SK, Lohr JW, Arora P. Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med. 2016 Nov 24;16(1):158. doi: 10.1186/s12890-016-0315-0. PMID: 27881110; PMCID: PMC5122151.
Kim MY, Boo S, Yoo M, Lee J, Kang NR. Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease. Int Urol Nephrol. 2017 Jul;49(7):1225-1232. doi: 10.1007/s11255-017-1572-4. Epub 2017 Apr 6. PMID: 28386744.
Zeng M, Chen Q, Liang W, He W, Zheng H, Huang C. Predictive value of ADAMTS-13 on concealed chronic renal failure in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017 Dec 5;12:3495-3501. doi: 10.2147/COPD.S151983. PMID: 29255356; PMCID: PMC5723126.
Pelaia C, Pastori D, Armentaro G, Miceli S, Cassano V, Barbara K, Pelaia G, Perticone M, Maio R, Pignatelli P, Violi F, Perticone F, Sesti G, Sciacqua A. Predictors of Renal Function Worsening in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Multicenter Observational Study. Nutrients. 2021 Aug 16;13(8):2811. doi: 10.3390/nu13082811. PMID: 34444971; PMCID: PMC8400083.
Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016 Jul;138(1):16-27. doi: 10.1016/j.jaci.2016.05.011. Epub 2016 May 27. PMID: 27373322.
Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004 Feb 18;291(7):844-50. doi: 10.1001/jama.291.7.844. PMID: 14970063.
Tan WC, Sin DD, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, Marciniuk DD, Maltais F, Buist AS, Road J, Hogg JC, Kirby M, Coxson H, Hague C, Leipsic J, O'Donnell DE, Aaron SD; CanCOLD Collaborative Research Group. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015 Sep;70(9):822-9. doi: 10.1136/thoraxjnl-2015-206938. Epub 2015 Jun 5. PMID: 26048404.
Kryvenko V. [Biomarkers of systemic inflammation, oxidative stress and their interactions in patients with combined flow of chronic obstructive pulmonary disease and arterial hypertension]. Georgian Med News. 2013 Mar;(216):23-8. Russian. PMID: 23567304.
Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014 Mar;35(1):71-86. doi: 10.1016/j.ccm.2013.10.004. Epub 2013 Dec 12. PMID: 24507838.
Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006 Jan;61(1):23-8. doi: 10.1136/thx.2005.042200. Epub 2005 Sep 2. PMID: 16143583; PMCID: PMC2080714.
Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009 Dec;41(6):631-8. doi: 10.1165/rcmb.2009-0220TR. Epub 2009 Aug 28. PMID: 19717810.
Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004 Jul;59(7):574-80. doi: 10.1136/thx.2003.019588. PMID: 15223864; PMCID: PMC1747070.
Harris B, Klein R, Jerosch-Herold M, Hoffman EA, Ahmed FS, Jacobs DR Jr, Klein BE, Wong TY, Lima JA, Cotch MF, Barr RG. The association of systemic microvascular changes with lung function and lung density: a cross-sectional study. PLoS One. 2012;7(12):e50224. doi: 10.1371/journal.pone.0050224. Epub 2012 Dec 20. PMID: 23284634; PMCID: PMC3527439.
Mapel DW, Marton JP. Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. Int J Chron Obstruct Pulmon Dis. 2013;8:127-34. doi: 10.2147/COPD.S40123. Epub 2013 Mar 15. PMID: 23515180; PMCID: PMC3600938.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Aprima Visgint, Sabrine Dwigint, Dara Vanka Trigint (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
